Abstract # 2508 Intensity-modulated Radiation Therapy (IMRT) for Non-small Cell Lung Cancer (NSCLC): Treatment Outcomes from a Small, Elderly Cohort

Presenter: Scarbrough, Todd

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

In this small, elderly cohort, tolerance of high-dose IMRT and concurrent chemotherapy was good and high-grade toxicities non-existent. OS and FFP for the 24 patient cohort compares very favorably to historical outcomes. Followup of these patients is very short at present however. There is a paucity of clinical outcomes data concerning IMRT treatment of advanced NSCLC. We find hypothesis-generating data that: 1) IMRT is a valid treatment option for Stage IIIA/B NSCLC, 2) “motion mitigation” (e.g. DIBH or gating) is worthy of consideration re: IMRT for NSCLC, and 3) PET response is prognostic of outcomes in this setting.

Abstracts Main Page | Logout